Company page

An2 Therapeutics, Inc.

An2 Therapeutics, Inc. is a public company traded under the ticker ANTX in the American market, with a market capitalization of approximately $180 million. The company focuses on developing innovative therapies for patients with serious diseases. An2 Therapeutics is dedicated to advancing its pipeline of treatments to address unmet medical needs.